GEMCITABINE ARROW 40 mg/ml, solution à diluer pour perfusion, Berzosertib (M6620)
IB 2018-04
Phase 2 small_molecule active
Quick answer
GEMCITABINE ARROW 40 mg/ml, solution à diluer pour perfusion, Berzosertib (M6620) for Adult patients with locally advanced/unresectable and/or metastatic soft-tissue leiomyosarcomas. is a Phase 2 program (small_molecule) at Institut für biomedizinische Analytik NMR-Imaging GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Institut für biomedizinische Analytik NMR-Imaging GmbH
- Indication
- Adult patients with locally advanced/unresectable and/or metastatic soft-tissue leiomyosarcomas.
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active